ROCKWELL MEDICAL, INC. Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments
ROCKWELL MEDICAL, INC. (RMTI) had Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments of $2.28 thousand as of 2012-12-31, per its 10-K filed 2013-03-18.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments · last filed 2013-03-18
- 2012-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $2.28K.
- 2011-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $8.75K.
| Period end | Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments |
|---|---|
| 2012-12-31 | $2.28K 10-K · filed 2013-03-18 |
| 2011-12-31 | $8.75K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |